EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs4949874 |
| Chromosomal location | Chr1: 75,934,477 (1p31.1) |
| Gene (distance) | ACADM (-28,153) |
| Predicted causal gene | ACADM |
| Gene/protein classification | - |
| Metabolite (Pathway) | acetylcarnitine (Carnitine metabolism; Lipid) hexanoylcarnitine (Carnitine metabolism; Lipid) |
| Biochemical locus-metabolite relationship | ACADM encodes a medium-chain specific acyl-CoA dehydrogenase with activity against a range of acyl-CoAs with chain lengths from 4 to 16 carbons. Peak activity was reported for hexanoyl-CoA [3597357]. The acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation: related to substrate and product ('activity'). ACADM acts on hexanoyl-CoA (interconverts with hexanoylcarnitine) and an end product of fatty acid degradation is acetyl-CoA (interconverts with acetylcarnitine) |
| eQTL associations | MSH4 (L) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | hexanoylcarnitine/oleate (18:1n9) [21886157]; C12/C10 [20037589] |
| Inborn error of metabolism | Medium chain acyl-CoA dehydrogenase deficiency |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |